St. Mary’s Hospital Medical Center: Myocardial Infarction Quality Measures

Myocardial Infarction
Quality Measures
Aspirin on admission
Beta blocker on admission
Aspirin at discharge
Beta blocker at discharge
ACEI or ARB
Chest pain center
Smoking cessation
Availability of PTCA
Inpatient mortality
Length of stay
Physician board certification
Lipid Lowering Therapy at Discharge
LDL Cholesterol Assessment
Quality Measures Home

Myocardial Infarction Quality Measures

Lipid Lowering Therapy at Discharge

According to the National Committee for Quality Assurance (NCQA): “Aggressive cholesterol lowering after a cardiac event can result in a 31 percent reduction in rates of fatal and nonfatal reinfarction [subsequent heart attack] and a 21 percent reduction in all causes of mortality. Screening and management of serum cholesterol, especially low-density lipoprotein (LDL-C), is an important and effective way to reduce the suffering and disability caused by coronary heart disease (CHD).”

A variety of cholesterol lowering medications are available, and when used in conjunction with the National Heart, Lung, and Blood Institute’s recommended therapeutic lifestyle changes (TLC), these medications can improve overall health and reduce the risk of death and disability.

Scroll to Top